TriMas (NASDAQ:TRS) Downgraded to “Sell” Rating by Wall Street Zen

Wall Street Zen downgraded shares of TriMas (NASDAQ:TRS) from a hold rating to a sell rating in a research report released on Saturday morning.

A number of other brokerages also recently commented on TRS. Weiss Ratings raised shares of TriMas from a “buy (b-)” rating to a “buy (b)” rating in a research report on Tuesday, June 23rd. BWS Financial reiterated a “buy” rating and issued a $45.00 target price on shares of TriMas in a research note on Monday, August 3rd. Finally, Zacks Research upgraded shares of TriMas from a “strong sell” rating to a “hold” rating in a research note on Tuesday, May 5th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $41.50.

TriMas Price Performance

NASDAQ:TRS opened at $38.94 on Friday. TriMas has a 1-year low of $30.43 and a 1-year high of $45.42. The company has a current ratio of 5.44, a quick ratio of 5.03 and a debt-to-equity ratio of 0.28. The firm has a fifty day simple moving average of $41.22 and a 200 day simple moving average of $38.77. The stock has a market capitalization of $1.40 billion, a PE ratio of 1.62 and a beta of 0.60.

TriMas (NASDAQ:TRS) last issued its earnings results on Thursday, July 30th. The industrial products company reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.03. TriMas had a net margin of 104.22% and a return on equity of 6.41%. The business had revenue of $174.58 million for the quarter, compared to the consensus estimate of $178.44 million. During the same period in the previous year, the company earned $0.61 earnings per share. The firm’s revenue for the quarter was down 36.5% on a year-over-year basis. TriMas has set its FY 2026 guidance at 1.600-1.700 EPS. On average, research analysts expect that TriMas will post 1.67 EPS for the current fiscal year.

TriMas Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 13th. Shareholders of record on Thursday, August 6th were issued a dividend of $0.04 per share. The ex-dividend date of this dividend was Thursday, August 6th. This represents a $0.16 annualized dividend and a yield of 0.4%. TriMas’s dividend payout ratio (DPR) is currently 0.67%.

Insider Buying and Selling

In other TriMas news, Director Herbert K. Parker sold 15,000 shares of TriMas stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $45.03, for a total transaction of $675,450.00. Following the completion of the transaction, the director directly owned 57,762 shares of the company’s stock, valued at $2,601,022.86. The trade was a 20.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 17.50% of the stock is currently owned by company insiders.

Institutional Trading of TriMas

A number of hedge funds have recently modified their holdings of the stock. Mariner LLC boosted its holdings in shares of TriMas by 2.2% during the 3rd quarter. Mariner LLC now owns 19,536 shares of the industrial products company’s stock worth $755,000 after buying an additional 414 shares during the period. Ellevest Inc. raised its holdings in TriMas by 11.6% in the 4th quarter. Ellevest Inc. now owns 6,418 shares of the industrial products company’s stock valued at $228,000 after acquiring an additional 669 shares during the period. AdvisorNet Financial Inc bought a new position in TriMas in the 1st quarter valued at about $28,000. Los Angeles Capital Management LLC acquired a new stake in TriMas during the fourth quarter worth approximately $29,000. Finally, Covestor Ltd lifted its position in TriMas by 20,525.0% during the fourth quarter. Covestor Ltd now owns 825 shares of the industrial products company’s stock worth $29,000 after acquiring an additional 821 shares during the last quarter. Institutional investors and hedge funds own 99.42% of the company’s stock.

Key Stories Impacting TriMas

Here are the key news stories impacting TriMas this week:

• Positive Sentiment: Director Daniel P. Tredwell purchased 64 TriMas shares for approximately $2,536 at an average price of $39.63. While the transaction was small relative to his existing holdings, insider buying can modestly improve investor sentiment. SEC insider transaction filing
• Positive Sentiment: Zacks Research raised its fiscal 2026 EPS forecast to $1.68 from $1.67, slightly above the broader consensus estimate of $1.66. It also increased its Q1 2028 forecast to $0.49 from $0.46.
• Neutral Sentiment: Zacks maintained a “Hold” rating on TriMas (TRS). The mixed estimate revisions suggest limited changes to the firm’s overall earnings outlook rather than a clear shift in sentiment.
• Negative Sentiment: Zacks lowered several quarterly forecasts, including Q3 2026 EPS to $0.51 from $0.52, Q4 2026 EPS to $0.41 from $0.42, Q2 2027 EPS to $0.57 from $0.58, Q3 2027 EPS to $0.58 from $0.59, and Q2 2028 EPS to $0.55 from $0.57. These reductions could weigh on expectations for near-term earnings growth.
• Negative Sentiment: Wall Street Zen downgraded TriMas to “Sell,” adding a more bearish analyst signal and potentially limiting upside despite the insider purchase and slight improvement in the full-year EPS forecast. TriMas downgraded to Sell at Wall Street Zen

About TriMas

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.